• Mashup Score: 0
    Washington University School of Medicine in St. Louis - 1 year(s) ago

    The purpose of this research study is to determine whether fluvoxamine reduces the symptoms of long COVID. 1. Participants must be 25 or older 2. Participant must self-report of past acute COVID episode within the last 3 months 3. Participants must report having trouble with memory or concentration For more information about this study, contact Volunteer for Health

    Source: studysearch.wustl.edu
    Categories: Infectious Disease, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of boulware_dr
      boulware_dr

      Thus, I am slightly skeptical that a SSRI at time of Long Covid is gonig to help, but that is different timing than initial acute therapy. However, such a double-blind RCT is important to conduct to test the hypothesis. One such trial seeking volunteers: https://t.co/WnVxN8mVyb